Exact Mass: 760.3517326000001

Exact Mass Matches: 760.3517326000001

Found 38 metabolites which its exact mass value is equals to given mass value 760.3517326000001, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

(1R,4S,7S,10R,13R,16S)-13-(1H-Indol-3-ylmethyl)-4-(2-methylpropyl)-7-(2-methylsulfanylethyl)-16-(phenylmethyl)-3,6,9,12,15,18,20-heptazabicyclo[8.8.4]docosane-2,5,8,11,14,17,21-heptone

(1R,4S,7S,10R,13R,16S)-13-(1H-indol-3-Ylmethyl)-4-(2-methylpropyl)-7-(2-methylsulphanylethyl)-16-(phenylmethyl)-3,6,9,12,15,18,20-heptazabicyclo[8.8.4]docosane-2,5,8,11,14,17,21-heptone

C38H48N8O7S (760.3366498)


   
   
   
   
   
   

4-Caffeoyl quinic acid, TMS

4-Caffeoyl quinic acid, TMS

C32H64O9Si6 (760.3165774)


   

trisorbicillinone A

trisorbicillinone A

C42H48O13 (760.3094758)


   
   
   
   

2-(O-beta-D-Glucopyranosyl)-16,25-diacetyl-cucurbitacine I

2-(O-beta-D-Glucopyranosyl)-16,25-diacetyl-cucurbitacine I

C40H56O14 (760.3669876)


   

3-O-{beta-D-galactopyranosyl-(1->2)-[beta-D-glucopyranosyl-(1->6)]-beta-D-glucopyranoside}-5alpha,14alpha-androst-8-ene

3-O-{beta-D-galactopyranosyl-(1->2)-[beta-D-glucopyranosyl-(1->6)]-beta-D-glucopyranoside}-5alpha,14alpha-androst-8-ene

C37H60O16 (760.388116)


   

LPIM1 18:1

2-O-(alpha-D-Manp)-(1-(9Z-octadecenoyl)-sn-glycero-3-phospho-1-myo-inositol)

C33H61O17P (760.3646186)


   

Oxotremorine sesquifumarate

Oxotremorine sesquifumarate

C36H48N4O14 (760.3166868)


   

Pipecuronium bromide

4,4-((2beta,3alpha,5alpha,16beta,17beta)-3,17-Bis(acetyloxy)androstane-2,16-diyl)bis(1,1-dimethyl-piperazinium) dibromide

C35H62Br2N4O4 (760.3137532)


D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents > D009466 - Neuromuscular Blocking Agents M - Musculo-skeletal system > M03 - Muscle relaxants > M03A - Muscle relaxants, peripherally acting agents D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists C78281 - Agent Affecting Musculoskeletal System > C29696 - Muscle Relaxant Pipecuronium bromide is a potent long-acting nondepolarizing steroidal neuromuscular blocking agent (NMBA), and a bisquaternary ammonium compound. Pipecuronium bromide is a powerful competitive nAChR antagonist with a Kd of 3.06 μM[1][2][3][4][5].

   

2-O-Methyl Uridine CED Phosphoramidite

2-O-Methyl Uridine CED Phosphoramidite

C40H49N4O9P (760.3236994)


DMT-2'O-Methyl-rU Phosphoramidite (2'-O-Me-U Phosphoramidite) is a 2'-O-Me derivative, and can be used for oligonucleotide synthesis[1][2].

   

(TETRAHYDRO-PYRAN-2-YL)ACETICACID

(TETRAHYDRO-PYRAN-2-YL)ACETICACID

C48H48MgN8 (760.3852228)


   

(1R,4S,7S,10R,13R,16S)-13-(1H-Indol-3-ylmethyl)-4-(2-methylpropyl)-7-(2-methylsulfanylethyl)-16-(phenylmethyl)-3,6,9,12,15,18,20-heptazabicyclo[8.8.4]docosane-2,5,8,11,14,17,21-heptone

(1R,4S,7S,10R,13R,16S)-13-(1H-indol-3-Ylmethyl)-4-(2-methylpropyl)-7-(2-methylsulphanylethyl)-16-(phenylmethyl)-3,6,9,12,15,18,20-heptazabicyclo[8.8.4]docosane-2,5,8,11,14,17,21-heptone

C38H48N8O7S (760.3366498)


   

N-{1-amino-6-[(5-nitro-2-furoyl)amino]-1-oxohexan-2-yl}-23-(indol-3-yl)-20-oxo-4,7,10,13,16-pentaoxa-19-azatricosan-1-amide

N-{1-amino-6-[(5-nitro-2-furoyl)amino]-1-oxohexan-2-yl}-23-(indol-3-yl)-20-oxo-4,7,10,13,16-pentaoxa-19-azatricosan-1-amide

C36H52N6O12 (760.3643032)


   

oct-7-en-1-yl alpha-L-fucopyranosyl-(1->2)-[alpha-D-galactopyranosyl-(1->3)]-beta-D-galactopyranosyl-(1->3)-beta-D-galactopyranoside

oct-7-en-1-yl alpha-L-fucopyranosyl-(1->2)-[alpha-D-galactopyranosyl-(1->3)]-beta-D-galactopyranosyl-(1->3)-beta-D-galactopyranoside

C32H56O20 (760.3364776000001)


   

oct-7-en-1-yl alpha-L-fucopyranosyl-(1->2)-[alpha-D-galactopyranosyl-(1->3)]-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranoside

oct-7-en-1-yl alpha-L-fucopyranosyl-(1->2)-[alpha-D-galactopyranosyl-(1->3)]-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranoside

C32H56O20 (760.3364776000001)


   

5-aminopentyl alpha-L-rhamnopyranosyl-(1->4)-[beta-L-rhamnopyranosyl-(1->4)-beta-D-glucopyranosyl-(1->3)]-2-acetamido-2-deoxy-beta-D-galactopyranoside

5-aminopentyl alpha-L-rhamnopyranosyl-(1->4)-[beta-L-rhamnopyranosyl-(1->4)-beta-D-glucopyranosyl-(1->3)]-2-acetamido-2-deoxy-beta-D-galactopyranoside

C31H56N2O19 (760.3477106)


   
   
   
   
   
   
   
   
   
   

2,6,8,9-tetrakis(acetyloxy)-4-(benzoyloxy)-3a-(2-hydroxypropan-2-yl)-1,8a-dimethyl-5-methylidene-2h,3h,4h,4ah,6h,7h,8h,9h,10h-cyclohexa[f]azulen-10-yl benzoate

2,6,8,9-tetrakis(acetyloxy)-4-(benzoyloxy)-3a-(2-hydroxypropan-2-yl)-1,8a-dimethyl-5-methylidene-2h,3h,4h,4ah,6h,7h,8h,9h,10h-cyclohexa[f]azulen-10-yl benzoate

C42H48O13 (760.3094758)


   

(8r)-8-ethyl-1,6,8,11-tetrahydroxy-10-{[5-({4-hydroxy-5-[(5-hydroxy-6-methyloxan-2-yl)oxy]-6-methyloxan-2-yl}oxy)-6-methyloxan-2-yl]oxy}-7-(hydroxymethyl)-7,9,10,11a-tetrahydro-5ah-tetracene-5,12-dione

(8r)-8-ethyl-1,6,8,11-tetrahydroxy-10-{[5-({4-hydroxy-5-[(5-hydroxy-6-methyloxan-2-yl)oxy]-6-methyloxan-2-yl}oxy)-6-methyloxan-2-yl]oxy}-7-(hydroxymethyl)-7,9,10,11a-tetrahydro-5ah-tetracene-5,12-dione

C39H52O15 (760.3306042)